Actelion to Accelerate Clinical Trials For Experimental Therapy That Treats MS, Other Autoimmune Diseases
Multiple Sclerosis News, News
Actelion Pharma recently announced that it will accelerate the launch of clinical trials involving its lead drug candidate ponesimod, an oral, selective sphingosine-1-phosphate (S1P1). This decision came after ... Read more